Category Archives: Others
Tramadol might Increase Suicide Risk
The US Food and Drug Administration (FDA) announced yesterday that it has added the warning label of suicide risk to tramadol hydrochloride (Ultram) and tramadol hydrochloride/acetaminophen (Ultracet). Ultram and Ultracet are opioid analgesic used for moderate to severe pain (such … Continue reading
Sugar-sweetened Beverages Increased the Risk of Gout
If you have hyperuricemia or gout, you should stop or reduce your intake of sugar-sweetened sodas, orange juice, and fructose, according to new research published online November 10 in the Journal of the American Medical Association. The data comes from the … Continue reading
Yunnan Baiyao Is an Effective Medicine to Stop Bleeding
Yunnan Baiyao is a well-known Chinese herbal medicine that has been used as a haemostatic drug for nearly 100 years. It was first formulated by Qu Huanzhong in the late Qing Dynasty. It was initially used as a topical haemostatic … Continue reading
Home Monitoring of INR is Equal to Clinic Care
For patients who are taking warfarin and need to check their INR every month at the clinics, the result of the following study might be a good news for them. A newly published article that suggests weekly self-testing of INR … Continue reading
FDA approves New Antibiotic for Pneumonia and Skin Infections
The US Food and Drug Administration (FDA) approves a new injectable antibiotic, ceftaroline fosamil (Teflaro; Forest Laboratories), for treating community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin-structure infections (ABSSSI), including the methicillin-resistant Staphylococcus aureus (MRSA). Ceftaroline is a … Continue reading
Hyperprolactinemia – Causes, Symptoms, Prognosis, Diagnosis and Latest Treatment
Hyperprolactinemia is one of the most common pituitary abnormalities, which is caused by an increased secretion of prolactin (above 20ng/ml) from the pituitary gland. Although the disorder is detected in less than 1% of the general population, it has been … Continue reading
FDA Approves Pegloticase (Krystexxa) for Refractory Gout
Good news for patients with gout. The US Food and Drug Administration (FDA) has just approved a new agent, pegloticase (Krystexxa) for gout patients who are refractory to conventional therapy. The approval was based on data from 2 replicate, multicenter, … Continue reading
History of Gout is linked to an Increase Risk of Heart Failure Events
It has been known that gout increases the risk of ischemic heart disease and mortality. A new study showed that gout is also associated with an increase risk of heart-failure hospitalization and death. In Montreal, Quebec, Canadian researchers performed an … Continue reading